The finding that the tumor of the index patient showed normal expression of MLH1 and PMS2 is consistent with the normal expression of the p.Asn338Ser variant; it is noteworthy that this tumor displayed loss of MSH2 and MSH6 expression, which would be compatible with an inactivating variant in the MSH2 gene. The gene discussed is MSH2; the disease is neoplasm.